Page results
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
File results
-
FOI/2023/0403 - Patients detained under the Mental Health Act - 2018-2023
-
FOI/2023/0410 - Clinical systems at the Trust
-
FOI/2023/0413 - Care hotels for patients used/ booked by Trust - 2022/23
-
FOI/2023/0414 - Operation cancelled for non-clinical reasons - 2018-2022
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities
-
FOI/2023/0416 - Treatments for non-small cell lung cancer
-
FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma
-
FOI/2023/0426 - Maternity services staffing levels
-
FOI/2023/0429 - Breast cancer treatment/ systemic anti-cancer therapies
-
FOI/2023/0430 - Number of operations performed to remove rectal foreign bodies